Original Articles

Submucosal injection of dexamethasone for the control of post-operative sequelae after mandibular third molar surgery

  1. Postgraduate Trainnee Dept of Oral and Maxillofacial Surgery, PAEC General Hospital, Islamabad
  2. HOD Dept of Oral and Maxillofacial Surgery, PAEC General Hospital, Islamabad
https://doi.org/10.48036/wt53dz84

Abstract

Objectives: To evaluate the efficacy of submucosal injection of 4mg/ml dexamethasone in comparison with normal saline (N/S) on mean post-operative pain, trismus, and swelling following mandibular third molar surgery.

Methodology: This randomized controlled trial was conducted at the Department of Oral and Maxillofacial Surgery, Pakistan Atomic Energy Commission General Hospital Islamabad, over a period of 1 year from October 2024 to September 2025. There were 70 patients in our study, who were divided into two equal groups of 35 patients each. Group A received 1 ml dexamethasone (4 mg/ml) by submucosal injection, and Group B received 1 ml normal saline (N/S) by the same route. Individuals of either gender aged 18–45 years who had an impacted mandibular third molar were included. Patients with known corticosteroid allergies, pericoronitis, uncontrolled comorbidities, pregnant or nursing women were excluded. To create an aseptic environment, patients were asked to rinse with 0.2% chlorhexidine mouthwash. Thirty minutes before the incision, a 3 ml syringe with a Luer lock 23G×1 thin wall needle was used to inject either 1 ml N/S or 4 mg/1 ml Dexamethasone submucosally in the posterior-buccal soft tissue of the tooth being extracted. VAS score, interincisal distance, distance between tragus to corner of the mouth, distance between angle of the mandible to lateral corner of the eye, distance between tragus to soft tissue pogonion, and the number of 500 mg tablets of paracetamol taken orally after surgery were recorded for the third and seventh postoperative day.

Results: In comparison to the control group, the study group reported considerably decreased pain on the 3rd and 7th postoperative days. Furthermore, the dexamethasone group experienced a substantial decrease in mean post-operative trismus and swelling.

Conclusion: Submucosal dexamethasone injection is a successful intervention for reducing post-operative pain, trismus and swelling after the surgical extraction of impacted mandibular third molars.

Metrics

0Abstract views
0Downloads

License

Copyright (c) 2026 Kanza Ateeque, Omar Arshad

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0/.) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More in this Issue